Cargando…
An assessment of prognostic immunity markers in breast cancer
Tumor-infiltrating lymphocytes (TIL) and immunity gene signatures have been reported to be significantly prognostic in breast cancer but have not yet been applied for calculation of risk of recurrence in clinical assays. A compact set of 17 immunity genes was derived herein from an Affymetrix-derive...
Autores principales: | Yang, Benlong, Chou, Jeff, Tao, Yaozhong, Wu, Dengbin, Wu, Xinhong, Li, Xueqing, Li, Yan, Chu, Yiwei, Tang, Feng, Shi, Yanxia, Ma, Linlin, Zhou, Tong, Kaufmann, William, Carey, Lisa A, Wu, Jiong, Hu, Zhiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206135/ https://www.ncbi.nlm.nih.gov/pubmed/30393759 http://dx.doi.org/10.1038/s41523-018-0088-0 |
Ejemplares similares
-
Development and Validation of a Robust Ferroptosis-Related Gene Panel for Breast Cancer Disease-Specific Survival
por: Li, Pei, et al.
Publicado: (2021) -
N-telopeptide as a potential diagnostic and prognostic marker for bone metastasis in human cancers: A meta-analysis
por: Li, Linlin, et al.
Publicado: (2023) -
Immediate Breast Reconstruction After Neoadjuvant Chemotherapy: Factors Associated With Surgical Selection and Complications
por: Chi, Weiru, et al.
Publicado: (2023) -
Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2− subtype breast cancer
por: Liu, Lei, et al.
Publicado: (2017) -
The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study
por: Li, Pei, et al.
Publicado: (2022)